Related Experiment Video
Updated: Jun 5, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
The Tuberculosis Relief Belt Project in the Republic of Korea: A 10-Year Review of Performance and Future Directions
Younghyun Kim1, Jin-Hwan Jeon1, Arang Back1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Korea.
Objectives:
This study evaluates the effectiveness and efficiency of the Tuberculosis (TB) Relief Belt Project (2014-2024) and proposes sustainable operational strategies by reviewing its role as a public health safety net and its policy impact.
Methods:
The project's implementation status, beneficiary characteristics, support case numbers, and institutional improvements were analyzed using annual reports, institutional performance data, policy research reports, and relevant academic literature from 2014 to 2024.
Results:
The TB Relief Belt Project expanded from four participating institutions in 2014 to 17 by 2024. During this expansion, the project consistently provided comprehensive, integrated services to vulnerable patients with TB, including medical expenses coverage, caregiving costs, transportation fees, nutritional support, and referral treatment costs. Notably, the number of cases receiving medical expense support increased substantially, from 31 in 2014 to 589 in 2024.
Conclusions:
Although the overall prevalence of TB is declining, vulnerable patients requiring support through the TB Relief Belt Project has continued to rise in number. This trend is attributable to the growth of economically disadvantaged populations, intensified outreach projects since 2019, and the expansion of eligibility for medical expense support following the introduction of the TB patient vulnerability assessment in 2022. Future efforts should focus on enhancing the project's sustainability and effectiveness by expanding into nonparticipating regions, strengthening engagement at existing institutions, and increasing project publicity.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
